Evidence map›Paper›PMID 28208769›Full record

ArticleInternational journal of molecular sciences2017

Localisation Microscopy of Breast Epithelial ErbB-2 Receptors and Gap Junctions: Trafficking after γ-Irradiation, Neuregulin-1β, and Trastuzumab Application.

Götz Pilarczyk, Ines Nesnidal, Manuel Gunkel, Margund Bach, Felix Bestvater, Michael Hausmann

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Götz PilarczykKirchhoff Institute for Physics, Im Neuenheimer Feld INF 227, D-69120 Heidelberg, Germany. goetz.pilarczyk@kip.uni-heidelberg.de.
Ines NesnidalKirchhoff Institute for Physics, Im Neuenheimer Feld INF 227, D-69120 Heidelberg, Germany. ines.nesnidal@kip.uni-heidelberg.de.
Manuel GunkelBioquant-University of Heidelberg, Im Neuenheimer Feld INF 267, D-69120 Heidelberg, Germany. manuel.gunkel@bioquant.uni-heidelberg.de.
Margund BachKirchhoff Institute for Physics, Im Neuenheimer Feld INF 227, D-69120 Heidelberg, Germany. margund.bach@kip.uni-heidelberg.de.
Felix BestvaterGerman Cancer Research Center, Im Neuenheimer Feld INF 280, D-69120 Heidelberg, Germany. f.bestvater@dkfz.de.
Michael HausmannKirchhoff Institute for Physics, Im Neuenheimer Feld INF 227, D-69120 Heidelberg, Germany. hausmann@kip.uni-heidelberg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In cancer, vulnerable breast epithelium malignance tendency correlates with number and activation of ErbB receptor tyrosine kinases. In the presented work, we observe ErbB receptors activated by irradiation-induced DNA injury or neuregulin- 1 β application, or alternatively, attenuated by a therapeutic antibody using high resolution fluorescence localization microscopy. The gap junction turnover coinciding with ErbB receptor activation and co-transport is simultaneously recorded. DNA injury caused by 4 Gray of 6 MeV photon γ -irradiation or alternatively neuregulin- 1 β application mobilized ErbB receptors in a nucleograde fashion-a process attenuated by trastuzumab antibody application. This was accompanied by increased receptor density, indicating packing into transport units. Factors mobilizing ErbB receptors also mobilized plasma membrane resident gap junction channels. The time course of ErbB receptor activation and gap junction mobilization recapitulates the time course of non-homologous end-joining DNA repair. We explain our findings under terms of DNA injury-induced membrane receptor tyrosine kinase activation and retrograde trafficking. In addition, we interpret the phenomenon of retrograde co-trafficking of gap junction connexons stimulated by ErbB receptor activation.

Indexed as

Antineoplastic AgentsConnexin 43EpitheliumErb-b2 Receptor Tyrosine KinasesGap JunctionsHumansMammary Glands, HumanMicroscopy, ConfocalNeuregulin-1Protein BindingProtein MultimerizationProtein TransportReceptor, ErbB-3TrastuzumabAntineoplastic AgentsConnexin 43Erb-b2 Receptor Tyrosine KinasesNeuregulin-1neuregulin betaReceptor, ErbB-3Trastuzumabbreast cancerDNA injuryErbB receptor tyrosin kinasegap junctionirradiationneuregulinretrograde traffickingspectral precision distance microscopytherapeutic antibody

Identifiers

PMID28208769
PMCPMC5343897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.